Mosapride Therapy

Mosapride Therapy is a pharmacological intervention within the class of prokinetic therapies that specifically employs mosapride, a selective 5-HT4 receptor agonist, to enhance gastrointestinal motility by stimulating acetylcholine release in the enteric nervous system.

125

Publications

4.4K

Citations

707

Authors

188

Institutions

Publications per year

2017–2026

16

Authors

707

  1. MT
    Miyako Takaki

    Nara Medical University, Japan

    6 publications · 186 citations

    6

    h-index

  2. HP
    Hyojin Park

    Yonsei University, South Korea

    6 publications · 159 citations

    6

    h-index

  3. NY
    Naoyuki Yoshida

    Sumitomo Dainippon Pharma (Japan), Japan

    6 publications · 241 citations

    6

    h-index

  4. KA
    Kyoichi Adachi

    Shimane University, Japan

    5 publications · 157 citations

    5

    h-index

  5. MH
    Masatoshi Hori

    The University of Tokyo, Japan

    4 publications · 210 citations

    4

    h-index

1–5 of 707

Venues

  1. Neurogastroenterology & Motility

    11 publications · 429 citations

    11

    h-index

  2. PubMed

    Repository · 10 publications · 206 citations

    10

    h-index

  3. Journal of Gastroenterology

    6 publications · 213 citations

    6

    h-index

  4. World Journal of Gastroenterology

    WJG · 5 publications · 154 citations

    5

    h-index

  5. Alimentary Pharmacology & Therapeutics

    5 publications · 408 citations

    5

    h-index

1–5